Getting "inside" Type i IFNs: Type i IFNs in Intracellular Bacterial Infections

Journal of Immunology Research

Volumn 2017, Issue , 2017, Pages

  Snyder, Deann T ^a   Hedges, Jodi F ^a   Jutila, Mark A ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

AUTOIMMUNITY; BACTERIAL INFECTION; BRUCELLA ABORTUS; BRUCELLOSIS; CHLAMYDIA MURIDARUM; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COXIELLA BURNETII; FRANCISELLA TULARENSIS; HUMAN; INTRACELLULAR MEMBRANE; INTRACELLULAR SIGNALING; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LISTERIA MONOCYTOGENES; LISTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; Q FEVER; REVIEW; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; TUBERCULOSIS; TULAREMIA; TYPHOID FEVER; ANIMAL; CYTOPLASM; IMMUNOLOGY; MACROPHAGE; MICROBIOLOGY; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIAL INFECTIONS; CYTOPLASM; HUMANS; INTERFERON TYPE I; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGES; MICE; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION;

EID: 85019126556     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2017/9361802     Document Type: Review

References (171)

1. V. van Pesch, H. Lanaya, J. C. Renauld, and T. Michiels, "Characterization of the murine alpha interferon gene family, " Journal of Virology, vol. 78, no. 15, pp. 8219-8228, 2004.
2. C. Dunn, M. Brunetto, G. Reynolds et al., "Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage, " Journal Experimental Medicine, vol. 204, no. 3, pp. 667-680, 2007.
3. M. Sarasin-Filipowicz, E. J. Oakeley, F. H. T. Duong et al., "Interferon signaling and treatment outcome in chronic hepatitis C, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 19, pp. 7034-7039, 2008.
4. E. B. Wilson, D. H. Yamada, H. Elsaesser et al., "Blockade of chronic type I interferon signaling to control persistent LCMV infection, " Science, vol. 340, no. 6129, pp. 202-207, 2013.
5. K. A. Hofmeyer, H. Jeon, and X. Zang, "The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion, " Journal of Biomedicine & Biotechnology, vol. 2011, Article ID 451694, p. 9, 2011.
6. I. Teige, A. Treschow, A. Teige et al., "IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis, " Journal of Immunology, vol. 170, no. 9, pp. 4776-4784, 2003.
7. C. Guiducci, M. Gong, Z. Xu et al., "TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus, " Nature, vol. 465, no. 7300, pp. 937-941, 2010.
8. T. Goldmann, T. Blank, and M. Prinz, "Fine-Tuning of type I IFN-signaling in microglia-implications for homeostasis, CNS autoimmunity and interferonopathies, " Current Opinion in Neurobiology, vol. 36, pp. 38-42, 2016.
9. A. N. Theofilopoulos, R. Baccala, B. Beutler, and D. H. Kono, "Type I interferons (alpha-beta) in immunity and autoimmunity, " Annual Review of Immunology, vol. 23, pp. 307-335, 2004.
10. R. Hernández-Pando, H. Orozcoe, A. Sampieri et al., "Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis, " Immunology, vol. 89, no. 1, pp. 26-33, 1996.
11. E. C. Borden, G. C. Sen, G. Uze et al., "Interferons at age 50: past, current and future impact on biomedicine, " Nature Reviews. Drug Discovery, vol. 6, no. 12, pp. 975-990, 2007.
12. H. M. Lazear, T. J. Nice, and M. S. Diamond, "Interferon-γ: immune functions at barrier surfaces and beyond, " Immunity, vol. 43, no. 1, pp. 15-28, 2015.
13. N. A. de Weerd, J. P. Vivian, T. K. Nguyen et al., "Structural basis of a unique interferon-[beta] signaling axis mediated via the receptor IFNAR1, " Nature Immunology, vol. 14, no. 9, pp. 901-907, 2013.
14. L. B. Ivashkiv and L. T. Donlin, "Regulation of type I interferon responses, " Nature Reviews. Immunology, vol. 14, no. 1, pp. 36-49, 2014.
15. P. Fitzgerald-Bocarsly, M. Feldman, M. Mendelsohn, S. Curl, and C. Lopez, "Human mononuclear cells which produce interferon-Alpha during NK(HSV-FS) assays are HLA-DR positive cells distinct from cytolytic natural killer effectors, " Journal of Leukocyte Biology, vol. 43, no. 4, pp. 323-334, 1988.
16. D. Parker and A. Prince, "Type I interferon response to extracellular bacteria in the airway epithelium, " Trends in Immunology, vol. 32, no. 12, pp. 582-588, 2011.
17. M. Charrel-Dennis, E. Latz, K. A. Halmen et al., "TLRindependent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA, " Cell Host & Microbe, vol. 4, no. 6, pp. 543-554, 2008.
18. T. B. Clarke and J. N. Weiser, "Intracellular sensors of extracellular bacteria, " Immunological Reviews, vol. 243, no. 1, pp. 9-25, 2011.
19. G. M. Boxx and G. Cheng, "The roles of type I interferon in bacterial infection, " Cell Host & Microbe, vol. 19, no. 6, pp. 760-769, 2016.
20. F. McNab, K. Mayer-Barber, A. Sher, A. Wack, and A. OGarra, "Type I interferons in infectious disease, " Nature Reviews. Immunology, vol. 15, no. 2, pp. 87-103, 2015.
21. L. Zitvogel, L. Galluzzi, O. Kepp, M. J. Smyth, and G. Kroemer, "Type I interferons in anticancer immunity, " Nature Reviews. Immunology, vol. 15, no. 7, pp. 405-414, 2015.
22. O. Takeuchi and S. Akira, "Pattern recognition receptors and inflammation, " Cell, vol. 140, no. 6, pp. 805-820, 2010.
23. S. Pandey, T. Kawai, and S. Akira, "Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors, " Cold Spring Harbor Perspectives in Biology, vol. 7, no. 1, article a016246, 2015.
24. A. M. Lundberg, S. K. Drexler, C. Monaco et al., "Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: A phenomenon absent from murine cell systems, " Blood, vol. 110, no. 9, p. 3245, 2007.
25. R. Barbalat, L. Lau, R. M. Locksley, and G. M. Barton, "Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands, " Nature Immunology, vol. 10, no. 11, pp. 1200-1207, 2009.
26. S. Uematsu and S. Akira, "Toll-like receptors and type I interferons, " The Journal of Biological Chemistry, vol. 282, no. 21, pp. 15319-15323, 2007.
27. T. W. Kim, K. Staschke, K. Bulek et al., "A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity, " The Journal of Experimental Medicine, vol. 204, no. 5, pp. 1025-1036, 2007.
28. H. Hemmi, O. Takeuchi, T. Kawai et al., "A Toll-like receptor recognizes bacterial DNA, " Nature, vol. 408, no. 6813, pp. 740-745, 2000.
29. A. Eaton-Bassiri, S. B. Dillon, M. Cunningham et al., "Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells, " Infection and Immunity, vol. 72, no. 12, pp. 7202-7211, 2004.
30. M. Adib-Conquy, D. Scott-Algara, J. M. Cavaillon, and F. Souza-Fonseca-Guimaraes, "TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals, " Immunology and Cell Biology, vol. 92, no. 3, pp. 256-262, 2014.
31. T. Kawai and S. Akira, "Pathogen recognition with Toll-like receptors, " Current Opinion in Immunology, vol. 17, no. 4, pp. 338-344, 2005.
32. R. Zhan, Q. Han, C. Zhang, Z. Tian, and J. Zhang, "Toll-like receptor 2 (TLR2) and TLR9 play opposing roles in host innate immunity against Salmonella enterica serovar Typhimurium infection, " Infection and Immunity, vol. 83, no. 4, pp. 1641-1649, 2015.
33. U. Bhan, G. Trujillo, K. Lyn-Kew et al., "Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila, " Infection and Immunity, vol. 76, no. 7, pp. 2895-2904, 2008.
34. N. Arpaia, J. Godec, L. Lau et al., "TLR signaling is required for Salmonella typhimurium virulence, " Cell, vol. 144, no. 5, pp. 675-688, 2011.
35. L. Y. Huang, K. J. Ishii, S. Akira, J. Aliberti, and B. Golding, "Th1-like cytokine induction by heat-killed Brucella abortus is dependent on triggering of TLR9, " Journal of Immunology, vol. 175, no. 6, p. 3964, 2005.
36. N. Lapaque, A. Muller, L. Alexopoulou, J. C. Howard, and J. P. Gorvel, "Brucella abortus induces Irgm3 and Irga6 expression via type-I IFN by a MyD88-dependent pathway, without the requirement of TLR2, TLR4, TLR5 and TLR9, " Microbial Pathogenesis, vol. 47, no. 6, pp. 299-304, 2009.
37. S. R. Paludan and A. G. Bowie, "Immune sensing of DNA, " Immunity, vol. 38, no. 5, pp. 870-880, 2013.
38. E. E. Gray, D. Winship, J. M. Snyder, S. J. Child, A. P. Geballe, and D. B. Stetson, "The AIM2-like receptors are dispensable for the interferon response to intracellular DNA, " Immunity, vol. 45, no. 2, pp. 255-266, 2016.
39. L. Sun, J. Wu, F. Du, X. Chen, and Z. J. Chen, "Cyclic GMPAMP synthase is a cytosolic DNA sensor that activates the type-I interferon pathway, " Science, vol. 339, no. 6121, p. 10, 2013.
40. A. C. Collins, H. Cai, T. Li et al., "Cyclic GMP-AMP synthase (cGAS) is an innate immune DNA sensor for Mycobacterium tuberculosis, " Cell Host & Microbe, vol. 17, no. 6, pp. 820-828, 2015.
41. R. Wassermann, M. Gulen, C. Sala et al., "Mycobacterium tuberculosis differentially activates cGAS-And inflammasome-dependent intracellular immune responses through ESX-1, " Cell Host & Microbe, vol. 17, no. 6, pp. 799-810, 2015.
42. R. O. Watson, S. L. Bell, D. A. MacDuff et al., "The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy, " Cell Host & Microbe, vol. 17, no. 6, pp. 811-819, 2015.
43. K. Hansen, T. Prabakaran, A. Laustsen et al., "Listeria monocytogenes induces IFNβ expression through an IFI16-, cGAS-And STING-dependent pathway, " The EMBO Journal, vol. 33, no. 15, pp. 1654-1666, 2014.
44. Y. Zhang, L. Yeruva, A. Marinov et al., "The DNA sensor, cyclic GMP-AMP synthase, is essential for induction of IFN-β during chlamydia trachomatis infection, " Journal of Immunology, vol. 193, no. 5, pp. 2394-2404, 2014.
45. S. R. Paludan, "Activation and regulation of DNA-driven immune responses, " Microbiology and Molecular Biology Reviews, vol. 79, no. 2, pp. 225-241, 2015.
46. A. Ablasser, F. Bauernfeind, G. Hartmann, E. Latz, K. A. Fitzgerald, and V. Hornung, "RIG-I dependent sensing of poly(dA-dT) via the induction of an RNA polymerase III transcribed RNA intermediate, " Nature Immunology, vol. 10, no. 10, pp. 1065-1072, 2009.
47. Y. H. Chiu, J. B. MacMillan, and Z. J. Chen, "RNA polymerase III detects cytosolic DNA and induces type-I interferons through the RIG-I pathway, " Cell, vol. 138, no. 3, pp. 576-591, 2009.
48. C. X. Koo, K. Kobiyama, Y. J. Shen et al., "RNA polymerase III regulates cytosolic RNA:DNA hybrids and intracellular microRNA expression, " The Journal of Biological Chemistry, vol. 290, no. 12, pp. 7463-7473, 2015.
49. Z. Abdullah, M. Schlee, S. Roth et al., "RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids, " The EMBO Journal, vol. 31, no. 21, pp. 4153-4164, 2012.
50. E. Dixit and J. C. Kagan, "Intracellular pathogen detection by RIG-I-like receptors, " Advances in Immunology, vol. 117, pp. 99-125, 2013.
51. H. Kato, O. Takeuchi, E. Mikamo-Satoh et al., "Lengthdependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-Associated gene 5, " Journal of Experimental Medicine, vol. 205, no. 7, pp. 1601-1610, 2008.
52. S. Jensen and A. R. Thomsen, "Sensing of RNA viruses: A review of innate immune receptors involved in recognizing RNA virus invasion, " Journal of Virology, vol. 86, no. 6, pp. 2900-2910, 2012.
53. S. Reikine, J. B. Nguyen, and Y. Modis, "Pattern recognition and signaling mechanisms of RIG-I and MDA5, " Frontiers in Immunology, vol. 5, p. 342, 2014.
54. K. R. Rodriguez, A. M. Bruns, and C. M. Horvath, "MDA5 and LGP2: Accomplices and antagonists of antiviral signal transduction, " Journal of Virology, vol. 88, no. 15, pp. 8194-8200, 2014.
55. V. Motta, F. Soares, T. Sun, and D. J. Philpott, "NOD-like receptors: versatile cytosolic sentinels, " Physiological Reviews, vol. 95, no. 1, p. 149, 2014.
56. G. Chen, M. H. Shaw, Y. G. Kim, and G. Nunez, "NOD-like receptors: role in innate immunity and inflammatory disease, " Annual Review of Pathology: Mechanisms of Disease, vol. 4, pp. 365-398, 2009.
57. S. E. Girardin, I. G. Boneca, J. Viala et al., "Nod2 is a general sensor of peptidoglycan through Muramyl dipeptide (MDP) detection, " The Journal of Biological Chemistry, vol. 278, no. 11, pp. 8869-8872, 2003.
58. S. E. Girardin, I. G. Boneca, L. A. M. Carneiro et al., "Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan, " Science, vol. 300, no. 5625, p. 1584, 2003.
59. Y. Zhong, A. Kinio, and M. Saleh, "Functions of NOD-like receptors in human diseases, " Frontiers in Immunology, vol. 4, p. 333, 2013.
60. A. Sabbah, T. H. Chang, R. Harnack et al., "Activation of innate immune antiviral responses by Nod2, " Nature Immunology, vol. 10, no. 10, pp. 1073-1080, 2009.
61. T. Watanabe, N. Asano, A. Kitani, I. J. Fuss, T. Chiba, and W. Strober, "NOD1-mediated mucosal host defense against helicobacter pylori, " International Journal of Inflammation, vol. 2010, Article ID 476482, p. 6, 2010.
62. I. M. Dambuza and G. D. Brown, "C-Type lectins in immunity: recent developments, " Current Opinion in Immunology, vol. 32, pp. 21-27, 2015.
63. J. C. Hoving, G. J. Wilson, and G. D. Brown, "Signalling C-Type lectin receptors, microbial recognition and immunity, " Cellular Microbiology, vol. 16, no. 2, pp. 185-194, 2014.
64. G. Trinchieri, "Type I interferon: friend or foe?" The Journal of Experimental Medicine, vol. 207, no. 10, pp. 2053-2063, 2010.
65. S. Kaur and L. C. Platanias, "IFN-[beta]-specific signaling via a unique IFNAR1 interaction, " Nature Immunology, vol. 14, no. 9, pp. 884-885, 2013.
66. L. C. Platanias, "Mechanisms of type-I-And type-IIinterferon-mediated signalling, " Nature Reviews. Immunology, vol. 5, no. 5, pp. 375-386, 2005.
67. A. K. Perry, G. Chen, D. Zheng, H. Tang, and G. Cheng, "The host type I interferon response to viral and bacterial infections, " Cell Research, vol. 15, no. 6, pp. 407-422, 2005.
68. H. Cho and B. L. Kelsall, "The role of type I interferons in intestinal infection, homeostasis, and inflammation, " Immunological Reviews, vol. 260, no. 1, pp. 145-167, 2014.
69. J. Kazar, J. D. Gillmore, and F. B. Gordon, "Effect of interferon and interferon inducers on infections with a nonviral intracellular microorganism, chlamydia trachomatis, " Infection and Immunity, vol. 3, no. 6, pp. 825-832, 1971.
70. L. M. de la Maza, E. M. Peterson, J. M. Goebel, C. W. Fennie, and C. W. Czarniecki, "Interferon-induced inhibition of chlamydia trachomatis: dissociation from antiviral and antiproliferative effects, " Infection and Immunity, vol. 47, no. 3, pp. 719-722, 1985.
71. T. Ishihara, M. Aga, K. Hino et al., "Inhibition of Chlamydia trachomatis growth by human interferon-Alpha: mechanisms and synergistic effect with interferon-gamma; and tumor necrosis factor-Alpha, " Biomedical Research, vol. 26, no. 4, pp. 179-185, 2005.
72. P. Puccetti, "On watching the watchers: IDO and type I/II IFN, " European Journal of Immunology, vol. 37, no. 4, pp. 876-879, 2007.
73. U. M. Nagarajan, D. Prantner, J. D. Sikes et al., "Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model, " Infection and Immunity, vol. 76, no. 10, pp. 4642-4648, 2008.
74. M. Rayamajhi, J. Humann, K. Penheiter, K. Andreasen, and L. L. Lenz, "Induction of IFN-Alpha-beta enables Listeria monocytogenes to suppress macrophage activation by IFNgamma, " The Journal of Experimental Medicine, vol. 207, no. 2, pp. 327-337, 2010.
75. B. Lukas and J. Hruskova, "A virus inhibitor circulating in the blood of chickens, induced by Francisella tularensis and Listeria monocytogenes, " Folia Microbiologia (Praha), vol. 12, no. 2, pp. 157-161, 1967.
76. E. A. Havell, "Augmented induction of interferons during Listeria monocytogenes infection, " The Journal of Infectious Diseases, vol. 153, no. 5, pp. 960-969, 1986.
77. E. A. Havell, "Listeria monocytogenes-induced interferongamma primes the host for production of tumor necrosis factor and interferon-Alpha/beta, " The Journal of Infectious Diseases, vol. 167, no. 6, pp. 1364-1371, 1993.
78. C. E. Witte, K. A. Archer, C. S. Rae, J. D. Sauer, J. J. Woodward, and D. A. Portnoy, "Chapter 8-innate immune pathways triggered by Listeria monocytogenes and their role in the induction of cell-mediated immunity, " in Advances in Immunology Immunity to Listeria monocytogenes, R. U. A. J. Emil, Ed., vol. 113, pp. 135-156, Academic Press, Cambridge, MA, USA, 2012.
79. K. A. Archer, J. Durack, and D. A. Portnoy, "STINGdependent type I IFN production inhibits cell-mediated immunity to Listeria monocytogenes, " PLoS Pathogens, vol. 10, no. 1, article e1003861, 2014.
80. C. A. Hagmann, A. M. Herzner, Z. Abdullah et al., "RIG-I detects triphosphorylated RNA of Listeria monocytogenes during infection in non-immune cells, " PLoS One, vol. 8, no. 4, article e62872, 2013.
81. J. H. Leber, G. T. Crimmins, S. Raghavan, N. P. Meyer-Morse, J. S. Cox, and D. A. Portnoy, "Distinct TLR-And NLR-mediated transcriptional responses to an intracellular pathogen, " PLoS Pathogens, vol. 4, no. 1, article e6, 2008.
82. D. B. Stetson and R. Medzhitov, "Recognition of cytosolic DNA activates an IRF3-dependent innate immune response, " Immunity, vol. 24, no. 1, pp. 93-103, 2006.
83. J. J. Woodward, A. T. Iavarone, and D. A. Portnoy, "C-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response, " Science, vol. 328, no. 5986, pp. 1703-1705, 2010.
84. D. L. Burdette, K. M. Monroe, K. Sotelo-Troha et al., "STING is a direct innate immune sensor of cyclic-di-GMP, " Nature, vol. 478, no. 7370, pp. 515-518, 2011.
85. K. T. Schwartz, J. D. Carleton, S. J. Quillin, S. D. Rollins, D. A. Portnoy, and J. H. Leber, "Hyperinduction of host beta interferon by a Listeria monocytogenes strain naturally overexpressing the multidrug efflux pump MdrT, " Infection and Immunity, vol. 80, no. 4, pp. 1537-1545, 2012.
86. K. J. Ishii, T. Kawagoe, S. Koyama et al., "TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines, " Nature, vol. 451, no. 7179, pp. 725-729, 2008.
87. R. M. OConnell, S. K. Saha, S. A. Vaidya et al., "Type I interferon production enhances susceptibility to Listeria monocytogenes infection, " Journal Experimental Medicine, vol. 200, no. 4, pp. 437-445, 2004.
88. J. A. Carrero, B. Calderon, and E. R. Unanue, "Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection, " Journal Experimental Medicine, vol. 200, no. 4, p. 535, 2004.
89. V. Auerbuch, D. G. Brockstedt, N. Meyer-Morse, M. ORiordan, and D. A. Portnoy, "Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes, " The Journal of Experimental Medicine, vol. 200, no. 4, pp. 527-533, 2004.
90. T. Reimer, M. Schweizer, and T. W. Jungi, "Type I IFN induction in response to Listeria monocytogenes in human macrophages: evidence for a differential activation of IFN regulatory factor 3 (IRF3), " Journal of Immunology, vol. 179, no. 2, p. 1166, 2007.
91. T. Henry, G. S. Kirimanjeswara, T. Ruby et al., "Type I interferon signaling constrains IL-17A/F secretion by γδ T cells during bacterial infections, " Journal of Immunology, vol. 184, no. 7, pp. 3755-3767, 2010.
92. S. E. Osborne, B. Sit, A. Shaker et al., "Type I interferon promotes cell-To-cell spread of Listeria monocytogenes, " Cellular Microbiology, vol. 19, no. 3, 2017.
93. S. J. Kearney, C. Delgado, E. M. Eshleman, K. K. Hill, B. P. OConnor, and L. L. Lenz, "Type I interferons down regulate myeloid cell IFNGR by inducing recruitment of an Egr3/Nab1 complex that silences ifngr1 transcription, " Journal of Immunology, vol. 191, no. 6, pp. 3384-3392, 2013.
94. M. G. Pitts, T. Myers-Morales, and S. E. F. DOrazio, "Type I IFN does not promote susceptibility to foodborne Listeria monocytogene, " Journal of Immunology, vol. 196, no. 7, p. 3109, 2016.
95. E. Kernbauer, V. Maier, I. Rauch, M. Möller, and T. Decker, "Route of infection determines the impact of type I interferons on innate immunity to Listeria monocytogenes, " PLoS One, vol. 8, no. 6, article e65007, 2013.
96. B. Lechartier, J. Rybniker, A. Zumla, and S. T. Cole, "Tuberculosis drug discovery in the post-post-genomic era, " EMBO Molecular Medicine, vol. 6, no. 2, pp. 158-168, 2014.
97. C. Manca, L. Tsenova, S. Freeman et al., "Hypervirulent M. Tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway, " Journal of Interferon & Cytokine Research, vol. 25, no. 11, pp. 694-701, 2005.
98. A. Dorhoi, V. Yeremeev, G. Nouailles et al., "Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics, " European Journal of Immunology, vol. 44, no. 8, pp. 2380-2393, 2014.
99. S. A. Stanley, J. E. Johndrow, P. Manzanillo, and J. S. Cox, "The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis, " Journal of Immunology, vol. 178, no. 5, p. 3143, 2007.
100. M. P. R. Berry, C. M. Graham, F. W. McNab et al., "An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis, " Nature, vol. 466, no. 7309, pp. 973-977, 2010.
101. A. K. Pandey, Y. Yang, Z. Jiang et al., "NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis, " PLoS Pathogens, vol. 5, no. 7, article e1000500, 2009.
102. E. J. M. Stoop, W. Bitter, and A. M. van der Sar, "Tubercle bacilli rely on a type VII army for pathogenicity, " Trends in Microbiology, vol. 20, no. 10, pp. 477-484, 2012.
103. B. B. Mishra, P. Moura-Alves, A. Sonawane et al., "Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome, " Cellular Microbiology, vol. 12, no. 8, pp. 1046-1063, 2010.
104. H. Saiga, S. Kitada, Y. Shimada et al., "Critical role of AIM2 in Mycobacterium tuberculosis infection, " International Immunology, vol. 24, no. 10, pp. 637-644, 2012.
105. C. Manca, L. Tsenova, A. Bergtold et al., "Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-Alpha-beta, " PNAS, vol. 98, no. 10, pp. 5752-5757, 2001.
106. F. Bouchonnet, N. Boechat, M. Bonay, and A. J. Hance, "Alpha/Beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG, " Infection and Immunity, vol. 70, no. 6, pp. 3020-3025, 2002.
107. L. Moreira-Teixeira, J. Sousa, F. W. McNab et al., "Type I IFN inhibits alternative macrophage activation during Mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-γ signaling, " Journal of Immunology, vol. 197, no. 12, pp. 4714-4726, 2016.
108. M. Lorkowski, A. Felipe-López, C. A. Danzer, N. Hansmeier, and M. Hensel, "Salmonella enterica invasion of polarized epithelial cells is a highly cooperative effort, " Infection and Immunity, vol. 82, no. 6, pp. 2657-2667, 2014.
109. C. G. Forest, E. Ferraro, S. C. Sabbagh, and F. Daigle, "Intracellular survival of Salmonella enterica serovar Typhi in human macrophages is independent of Salmonella pathogenicity island (SPI)-2, " Microbiology, vol. 156, Part 12, pp. 3689-3698, 2010.
110. O. Steele-Mortimer, J. H. Brumell, L. A. Knodler, S. Méresse, A. Lopez, and B. B. Finlay, "The invasion-Associated type III secretion system of Salmonella enterica serovar Typhimurium is necessary for intracellular proliferation and vacuole biogenesis in epithelial cells, " Cellular Microbiology, vol. 4, no. 1, pp. 43-54, 2002.
111. P. Broz, K. Newton, M. Lamkanfi, S. Mariathasan, V. M. Dixit, and D. M. Monack, "Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella, " The Journal of Experimental Medicine, vol. 207, no. 8, pp. 1745-1755, 2010.
112. P. Broz, T. Ruby, K. Belhocine et al., "Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1, " Nature, vol. 490, no. 7419, pp. 288-291, 2012.
113. K. A. Owen, C. J. Anderson, and J. E. Casanova, "Salmonella suppresses the TRIF-dependent type I interferon response in macrophages, " MBio, vol. 7, no. 1, article e02051-15, 2016.
114. M. Schmolke, J. R. Patel, E. de Castro et al., "RIG-I detects mRNA of intracellular Salmonella enterica serovar Typhimurium during bacterial infection, " MBio, vol. 5, no. 2, article e01006-14, 2014.
115. M. Lara-Tejero, F. S. Sutterwala, Y. Ogura et al., "Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis, " The Journal of Experimental Medicine, vol. 203, no. 6, pp. 1407-1412, 2006.
116. B. Raupach, S. K. Peuschel, D. M. Monack, and A. Zychlinsky, "Caspase-1-mediated activation of interleukin-1b (IL-1β) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection, " Infection and Immunity, vol. 74, no. 8, pp. 4922-4926, 2006.
117. N. Kayagaki, S. Warming, M. Lamkanfi et al., "Non-canonical inflammasome activation targets caspase-11, " Nature, vol. 479, no. 7371, pp. 117-121, 2011.
118. E. A. Miao, D. P. Mao, N. Yudkovsky et al., "Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 7, pp. 3076-3080, 2010.
119. G. Bukholm, B. P. Berdal, C. Haug, and M. Degré, "Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice, " Infection and Immunity, vol. 45, no. 1, pp. 62-66, 1984.
120. N. Robinson, S. McComb, R. Mulligan, R. Dudani, L. Krishnan, and S. Sad, "Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium, " Nature Immunology, vol. 13, no. 10, pp. 954-962, 2012.
121. P. Vandenabeele, W. Declercq, F. Van Herreweghe, and T. Vanden Berghe, "The role of the kinases RIP1 and RIP3 in TNF-induced necrosis, " Science Signaling, vol. 3, no. 115, p. re4, 2010.
122. D. J. Perkins, R. Rajaiah, S. M. Tennant et al., "Salmonella typhimurium co-opts the host type I IFN system to restrict macrophage innate immune transcriptional responses selectively, " Journal of Immunology, vol. 195, no. 5, pp. 2461-2471, 2015.
123. C. Dilantika, E. R. Sedyaningsih, M. R. Kasper et al., "Influenza virus infection among pediatric patients reporting diarrhea and influenza-like illness, " BMC Infectious Diseases, vol. 10, no. 1, p. 3, 2010.
124. E. Deriu, G. M. Boxx, X. He et al., "Influenza virus affects intestinal microbiota and secondary Salmonella infection in the gut through type I interferons, " PLoS Pathogens, vol. 12, no. 5, article e1005572, 2016.
125. M. A. Freudenberg, T. Merlin, C. Kalis, Y. Chvatchko, H. Stöbig, and C. Galanos, "Cutting edge: A murine, IL-12-independent pathway of IFN-gamma induction by gramnegative bacteria based on STAT4 activation by type I IFN and IL-18 signaling, " Journal of Immunology, vol. 169, no. 4, pp. 1665-1668, 2002.
126. T. Henry, A. Brotcke, D. S. Weiss, L. J. Thompson, and D. M. Monack, "Type I interferon signaling is required for activation of the inflammasome during Francisella infection, " The Journal of Experimental Medicine, vol. 204, no. 5, pp. 987-994, 2007.
127. C. Checroun, T. D. Wehrly, E. R. Fischer, S. F. Hayes, and J. Celli, "Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 39, pp. 14578-14583, 2006.
128. L. A. Allen, "Interview with Dr. Lee-Ann Allen regarding pivotal advance: Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape, " Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1222-1223, 2006.
129. J. D. Hall, M. D. Woolard, B. M. Gunn et al., "Infectedhost-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112, " Infection and Immunity, vol. 76, no. 12, pp. 5843-5852, 2008.
130. G. S. Baron and F. E. Nano, "MglA and MglB are required for the intramacrophage growth of Francisella novicida, " Molecular Microbiology, vol. 29, no. 1, pp. 247-259, 1998.
131. M. Santic, M. Molmeret, K. E. Klose, S. Jones, and Y. A. Kwaik, "The Francisella tularensis pathogenicity island protein IglC and its regulator MglA are essential for modulating phagosome biogenesis and subsequent bacterial escape into the cytoplasm, " Cellular Microbiology, vol. 7, no. 7, pp. 969-979, 2005.
132. S. Mariathasan, D. S. Weiss, V. M. Dixit, and D. M. Monack, "Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis, " The Journal of Experimental Medicine, vol. 202, no. 8, pp. 1043-1049, 2005.
133. M. A. Gavrilin, I. J. Bouakl, N. L. Knatz et al., "Internalization and phagosome escape required for Francisella to induce human monocyte IL-1β processing and release, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 1, pp. 141-146, 2006.
134. A. M. Hajjar, M. D. Harvey, S. A. Shaffer et al., "Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors, " Infection and Immunity, vol. 74, no. 12, pp. 6730-6738, 2006.
135. K. M. Storek, N. A. Gertsvolf, M. B. Ohlson, and D. M. Monack, "cGAS and Ifi204 cooperate to produce type I IFNs in response to Francisella infection, " Journal of Immunology, vol. 194, no. 7, pp. 3236-3245, 2015.
136. K. A. Fitzgerald and V. A. K. Rathinam, "GBPs take AIM at Francisella, " Nature Immunology, vol. 16, no. 5, pp. 443-444, 2015.
137. S. M. Man, R. Karki, R. K. S. Malireddi et al., "The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection, " Nature Immunology, vol. 16, no. 5, pp. 467-475, 2015.
138. E. Meunier, P. Wallet, R. F. Dreier et al., "Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida, " Nature Immunology, vol. 16, no. 5, pp. 476-484, 2015.
139. B. H. Kim, A. R. Shenoy, P. Kumar, R. Das, S. Tiwari, and J. D. MacMicking, "A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial infection, " Science, vol. 332, no. 6030, pp. 717-721, 2011.
140. J. Celli, C. de Chastellier, D. M. Franchini, J. Pizarro-Cerda, E. Moreno, and J. P. Gorvel, "Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum, " Journal Experimental. Medicine, vol. 198, no. 4, pp. 545-556, 2003.
141. S. P. Salcedo, M. I. Marchesini, H. Lelouard et al., "Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1, " PLoS Pathogens, vol. 4, no. 2, article e21, 2008.
142. X. Li and Y. He, "Caspase-2-dependent dendritic cell death, maturation, and priming of T cells in response to Brucella abortus infection, " PLoS One, vol. 7, no. 8, article e43512, 2012.
143. M. T. Gomes, P. C. Campos, L. A. de Almeida et al., "The role of innate immune signals in immunity to Brucella abortus, " Frontiers in Cellular and Infection Microbiology, vol. 2, p. 130, 2012.
144. L. A. de Almeida, N. B. Carvalho, F. S. Oliveira et al., "MyD88 and STING signaling pathways are required for IRF3-mediated IFN-+ induction in response to Brucella abortus infection, " PLoS One, vol. 6, no. 8, article e23135, 2011.
145. C. M. Roux, H. G. Rolán, R. L. Santos et al., "Brucella requires a functional Type IV secretion system to elicit innate immune responses in mice, " Cellular Microbiology, vol. 9, no. 7, pp. 1851-1869, 2007.
146. A. L. Neild and C. R. Roy, "Immunity to vacuolar pathogens: what can we learn from Legionella?" Cellular Microbiology, vol. 6, no. 11, pp. 1011-1018, 2004.
147. G. Segal, M. Feldman, and T. Zusman, "The Icm/Dot type-IV secretion systems of Legionella pneumophila and Coxiella burnetii, " FEMS Microbiology Reviews, vol. 29, no. 1, pp. 65-81, 2005.
148. A. M. Richards, J. E. Von Dwingelo, C. T. Price, and Y. Abu Kwaik, "Cellular microbiology and molecular ecology of Legionella-Amoeba interaction, " Virulence, vol. 4, no. 4, pp. 307-314, 2013.
149. G. Schiavoni, C. Mauri, D. Carlei, F. Belardelli, M. Castellani Pastoris, and E. Proietti, "Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-γ-independent pathway, " Journal of Immunology, vol. 173, no. 2, pp. 1266-1275, 2004.
150. B. Opitz, M. Vinzing, V. van Laak et al., "Legionella pneumophila induces IFNβ in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication, " The Journal of Biological Chemistry, vol. 281, no. 47, pp. 36173-36179, 2006.
151. K. M. Monroe, S. M. McWhirter, and R. E. Vance, "Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to Legionella pneumophila, " PLoS Pathogens, vol. 5, no. 11, article e1000665, 2009.
152. A. A. Abdul-Sater, I. Tattoli, L. Jin et al., "Cyclic-di-GMP and cyclic-di-AMP activate the NLRP3 inflammasome, " EMBO Reports, vol. 14, no. 10, pp. 900-906, 2013.
153. J. Lippmann, H. C. Möller, J. Naujoks et al., "Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice, " Cellular Microbiology, vol. 13, no. 11, pp. 1668-1682, 2011.
154. C. R. Plumlee, C. Lee, A. A. Beg, T. Decker, H. A. Shuman, and C. Schindler, "Interferons direct an effective innate response to Legionella pneumophila infection, " The Journal of Biological Chemistry, vol. 284, no. 44, pp. 30058-30066, 2009.
155. A. A. Abdul-Sater, A. Majoros, C. Plumlee et al., "Different STAT transcription complexes drive early and delayed responses to type I IFNs, " Journal of Immunology, vol. 195, no. 1, pp. 210-216, 2015.
156. D. K. Y. Ang, C. V. L. Oates, R. Schuelein et al., "Cutting edge: pulmonary Legionella pneumophila is controlled by Plasmacytoid dendritic cells but not type I IFN, " Journal of Immunology, vol. 184, no. 10, pp. 5429-5433, 2010.
157. M. Calverley, S. Erickson, A. J. Read, and A. G. Harmsen, "Resident alveolar macrophages are susceptible to and permissive of Coxiella burnetii infection, " PLoS One, vol. 7, no. 12, article e51941, 2012.
158. R. A. Heinzen, M. A. Scidmore, D. D. Rockey, and T. Hackstadt, "Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and chlamydia trachomatis, " Infection and Immunity, vol. 64, no. 3, pp. 796-809, 1996.
159. S. Meconi, C. Capo, M. Remacle-Bonnet, G. Pommier, D. Raoult, and J. L. Mege, "Activation of protein tyrosine kinases by Coxiella burnetii: role in actin cytoskeleton reorganization and bacterial phagocytosis, " Infection and Immunity, vol. 69, no. 4, pp. 2520-2526, 2001.
160. P. S. Romano, M. G. Gutierrez, W. Berón, M. Rabinovitch, and M. I. Colombo, "The autophagic pathway is actively modulated by phase II Coxiella burnetii to efficiently replicate in the host cell, " Cellular Microbiology, vol. 9, no. 4, pp. 891-909, 2007.
161. A. O. Barry, N. Boucherit, G. Mottola et al., "Impaired stimulation of p38α-MAPK/Vps41-HOPS by LPS from pathogenic Coxiella burnetii prevents trafficking to microbicidal phagolysosomes, " Cell Host & Microbe, vol. 12, no. 6, pp. 751-763, 2012.
162. J. Dellacasagrande, C. Capo, D. Raoult, and J. L. Mege, "IFN-γ mediated control of Coxiella burnetii survival in monocytes: The role of cell apoptosis and TNF, " Journal of Immunology, vol. 162, no. 4, pp. 2259-2265, 1999.
163. A. Honstettre, G. Imbert, E. Ghigo et al., "Dysregulation of cytokines in acute Q fever: role of interleukin-10 and tumor necrosis factor in chronic evolution of Q fever, " The Journal of Infectious Diseases, vol. 187, no. 6, pp. 956-962, 2003.
164. E. Ghigo, A. Honstettre, C. Capo, J. P. Gorvel, D. Raoult, and J. L. Mege, "Link between impaired maturation of phagosomes and defective Coxiella burnetii killing in patients with chronic Q fever, " The Journal of Infectious Diseases, vol. 190, no. 10, pp. 1767-1772, 2004.
165. S. Meghari, Y. Bechah, C. Capo et al., "Persistent Coxiella burnetii infection in mice overexpressing IL-10: An efficient model for chronic Q fever pathogenesis, " PLoS Pathogens, vol. 4, no. 2, article e23, 2008.
166. K. P. Williams, J. J. Gillespie, B. W. S. Sobral et al., "Phylogeny of gammaproteobacteria, " Journal of Bacteriology, vol. 192, no. 9, pp. 2305-2314, 2010.
167. J. F. Hedges, A. Robison, E. Kimmel et al., "Type I IFN counters or promotes Coxiella burnetii replication dependent on tissue, " Infection and Immunity, vol. 84, no. 6, pp. 1815-1825, 2016.
168. E. J. van Schaik, C. Chen, K. Mertens, M. M. Weber, and J. E. Samuel, "Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii, " Nature Reviews. Microbiology, vol. 11, no. 8, pp. 561-573, 2013.
169. M. B. Ka, S. Mezouar, A. Ben Amara et al., "Coxiella burnetii induces inflammatory interferon-like signature in plasmacytoid dendritic cells: A new feature of immune response in Q fever, " Frontiers in Cellular and Infection Microbiology, vol. 6, p. 70, 2016.
170. P. S. Redford, K. D. Mayer-Barber, F. W. McNab et al., "Influenza a virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptordependent pathway, " The Journal of Infectious Diseases, vol. 209, no. 2, pp. 270-274, 2014.
171. G. J. Kersh, "Antimicrobial therapies for Q fever, " Expert Review of Anti-Infective Therapy, vol. 11, no. 11, pp. 1207-1214, 2013.